Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

被引：0
|
作者：
Leitner, H.
机构：
来源：
AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | 2016年 / 9卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [41] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Rawshani, Aidin
    Rawshani, Araz
    Franzen, Stefan
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Miftaraj, Mervete
    McGuire, Darren K.
    Sattar, Naveed
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15): : 1407 - 1418
  • [42] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Martinez-Ceron, Elisabet
    Garcia-Rio, Francisco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (03): : 300 - 300
  • [43] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Htay, Thwe
    Soe, Kyaw
    Lopez-Perez, Arianna
    Amy HoangAnh Doan
    Romagosa, Michael A.
    Aung, KoKo
    [J]. CURRENT CARDIOLOGY REPORTS, 2019, 21 (06)
  • [44] Dapagliflozin versus Empagliflozin and the Risk for Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Nationwide Population-Based Study
    Lim, Jaehyun
    Kim, Bongseong
    Choi, You-Jung
    Lee, Hyun-Jung
    Han, Kyung-Do
    Lee, Heesun
    Park, Jun-bean
    Kim, Hyung-Kwan
    Kim, Yong-Jin
    [J]. CIRCULATION, 2022, 146
  • [45] Empagliflozin: A Review in Type 2 Diabetes
    Frampton, James E.
    [J]. DRUGS, 2018, 78 (10) : 1037 - 1048
  • [46] Empagliflozin: A Review in Type 2 Diabetes
    James E. Frampton
    [J]. Drugs, 2018, 78 : 1037 - 1048
  • [47] Empagliflozin for the treatment of type 2 diabetes
    Jahagirdar, Vidhya
    Barnett, Anthony H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2429 - 2441
  • [48] Empagliflozin for the treatment of Type 2 diabetes
    Komala, Muralikrishna Gangadharan
    Mather, Amanda
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (03) : 271 - 279
  • [49] MODELLING CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES IN THE ERA OF CARDIOVASCULAR OUTCOMES TRIALS
    McEwan, P.
    Chubb, B.
    Bennett, H.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A747 - A747
  • [50] Serum Phosphorus and Cardiovascular Mortality in Type 2 Diabetes
    Chonchol, Michel
    Dale, Rita
    Schrier, Robert W.
    Estacio, Raymond
    [J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (04): : 380 - 386
12345